Kate Hollinshead

Senior Scientist, Translational Science

Focus at NTx

Gene therapy, delivery, toxicity & immunogenicity


I have over 10 years’ experience in oncology, biotechnology, and pharmaceutical drug discovery and development. I completed a degree in Biochemistry and a Ph.D. in Cancer Biochemistry at The University of Birmingham, U.K., with industrial placements and MedImmune in Biopharmaceutical Development and AstraZeneca in Discovery Oncology. I subsequently researched pancreatic cancer at NYU Langone Health. My academic pursuits focused on identifying metabolic vulnerabilities in cancer and initiated the therapeutic development of two biological targets. At NanoVation, I am translating these skillsets to identify gene therapy strategies that showcase NanoVation’s proprietary technology and strengthen the company’s therapeutic pipeline.

Interests / hobbies

My cats, hiking, travel, music, art & food